Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Perfusion
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Asimakopoulos, G.
Right arrow Articles by Gourlay, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asimakopoulos, G.
Right arrow Articles by Gourlay, T.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A review of anti-inflammatory strategies in cardiac surgery

George Asimakopoulos

Cardiothoracic Surgery, West London Rotation, UK, geoasi{at}hotmail.com

Terence Gourlay

Cardiothoracic Surgery, NHLI Imperial College Faculty of Medicine, London, UK

It is generally accepted that cardiac surgery is frequently associated with the development of systemic inflammatory response. This phenomenon is very variable clinically, and can be detected by measuring plasma concentrations of certain inflammatory markers. Complement component, cytokines and adhesion molecules are examples of these markers. Systemic inflammation can be potentially damaging to major organs. Several anti-inflammatory strategies have been used in recent years, aiming to attenuate the development of systemic inflammatory response. This article summarizes recently published literature concerning the use of anti-inflammatory techniques and pharmacological agents in cardiac surgery. In particular, the anti-inflammatory effects of off-pump surgery, leukocyte filtration, corticosteroids, aprotinin, phosphodiesterase inhibitors, dpoexamine, H2 antagonists and ACE inhibitors are reviewed. The overall conclusion is that although certain strategies reduce plasma levels of inflammatory mediators, convincing evidence of significant clinical benefits is yet to come.

Perfusion, Vol. 18, No. 1 suppl, 7-12 (2003)
DOI: 10.1191/0267659103pf623oa
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Lab AnimHome page
O. Levionnois and P. Kronen
Development of post-pump syndrome in a sheep after mitral valve stenting
Lab Anim, October 1, 2008; 42(4): 505 - 510.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
H. Heinze, C. Rosemann, C. Weber, G. Heinrichs, L. Bahlmann, M. Misfeld, M. Heringlake, and W. Eichler
A single prophylactic dose of pentoxifylline reduces high dependency unit time in cardiac surgery -- a prospective randomized and controlled study
Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 83 - 89.
[Abstract] [Full Text] [PDF]